Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Pol Specenier"'
Autor:
Cindy Kenis, Lore Decoster, Johan Flamaing, Philip R. Debruyne, Inge De Groof, Christian Focan, Frank Cornélis, Vincent Verschaeve, Christian Bachmann, Dominique Bron, Heidi Van den Bulck, Dirk Schrijvers, Christine Langenaeken, Pol Specenier, Guy Jerusalem, Jean-Philippe Praet, Jessie De Cock, Jean-Pierre Lobelle, Hans Wildiers, Koen Milisen
Publikováno v:
BMC Geriatrics, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Falls and fall-related injuries are a major public health problem. Data on falls in older persons with cancer is limited and robust data on falls within those with a frailty profile are missing. The aim of this study is to investi
Externí odkaz:
https://doaj.org/article/bf52381393b7483d81bf534bf0fcbe9e
Autor:
Anne Sophie Bonte, Olivier Peetermans, Sabriya Sirimsi, G. Van Haesendonck, İbrahim Ocak, Steven Mariën, Pol Specenier, Julien Lambert, Olivier Vanderveken
Publikováno v:
B-ENT, Vol 17, Iss 3, Pp 201-208 (2021)
Externí odkaz:
https://doaj.org/article/747a8ac24f874ca2b925d05bc87143fd
Autor:
Margot Baudelet, Leen Van den Steen, Fréderic Duprez, Marc De Bodt, Sarah Deschuymer, Ann Goeleven, Isabel Hutsebaut, Steven Mariën, Sabine Meersschout, Daan Nevens, Sandra Nuyts, Marc Peeters, Pol Specenier, Michiel Van den Brekel, Lisette van der Molen, Caroline Vandenbruaene, Olivier Vanderveken, Joost Van Dinther, Carl Van Laer, Tom Vauterin, Hilde Verstraete, Gwen Van Nuffelen, Member of the Belgian PRESTO Group
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-10 (2020)
Abstract Background Dysphagia is a common and serious complication after (chemo)radiotherapy (CRT) for head-and-neck cancer (HNC) patients. Prophylactic swallowing exercises (PSE) can have a significantly positive effect on post-treatment swallowing
Externí odkaz:
https://doaj.org/article/1196c6d666b74d689ea0b6a6a4e0ecf7
Autor:
Jolien Van denBossche, Christophe Deben, Ines De Pauw, Hilde Lambrechts, Christophe Hermans, Vanessa Deschoolmeester, Julie Jacobs, Pol Specenier, Patrick Pauwels, Jan Baptist Vermorken, Marc Peeters, Filip Lardon, An Wouters
Publikováno v:
Molecular Oncology, Vol 13, Iss 5, Pp 1196-1213 (2019)
Polo‐like kinase 1 (Plk1), a master regulator of mitosis and the DNA damage response, is considered to be an intriguing target in the research field of mitotic intervention. The observation that Plk1 is overexpressed in multiple human malignancies,
Externí odkaz:
https://doaj.org/article/a24f271f49c04d979044944246887aba
Autor:
Margot Geens, Sofie Stappers, Heleen Konings, Benedicte Y De Winter, Pol Specenier, Jan P Van Meerbeeck, Gert A Verpooten, Steven Abrams, Annelies Janssens, Marc Peeters, Paul Van de Heyning, Olivier M Vanderveken, Kristien J Ledeganck
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0252646 (2021)
In this study, we investigated serum epidermal growth factor (EGF) in an oncological population of head- and neck and pulmonary neoplasms and whether serum EGF could serve as a prognostic marker of survival and as a predictive marker for treatment re
Externí odkaz:
https://doaj.org/article/599d207c84594a2fa43102b4cb08af5c
Autor:
Heleen Konings, Sofie Stappers, Margot Geens, Benedicte Y. De Winter, Kevin Lamote, Jan P. van Meerbeeck, Pol Specenier, Olivier M. Vanderveken, Kristien J. Ledeganck
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Head and neck neoplasms have a poor prognosis because of their late diagnosis. Finding a biomarker to detect these tumors in an early phase could improve the prognosis and survival rate. This literature review provides an overview of biomarkers, cove
Externí odkaz:
https://doaj.org/article/8f318fa2d6e4458092295e240254cea4
Autor:
Julien Lambert, Pol Specenier, Olivier M. Vanderveken, Steven Mariën, Sabriya Sirimsi, Anne Sophie Bonte, Ibrahim Ocak, G. Van Haesendonck, Olivier Peetermans
Publikováno v:
B-ENT, Vol 17, Iss 3, Pp 201-208 (2021)
B-ENT
B-ENT
Melanomas are malignant tumors arising from melanocytes. A vast majority of melanomas occur on cutaneous surfaces. Rarely, melanomas can also be found in various extracutaneous sites where melanocytes are scarcely present. Here, we present a 58-year-
Autor:
Keith C. Bible, Irene Brana, Mollie Leoni, Stephan Hackenberg, Jessica Bauman, Pol Specenier, Jérôme Fayette, Catherine Rose Scholz, Binaifer Balsara, Maria Jose Flor, Bridget Martell, Alan L. Ho, Robert I. Haddad, Valentina Boni, Caroline Even, Sjoukje F. Oosting, Sung-Bae Kim, Kevin J. Harrington, Nabil F. Saba, Francis P. Worden, Antonio Gualberto, Lisa Licitra, Ioanna Nixon, Deborah J. Wong, Myung-Ju Ahn
Publikováno v:
Journal of clinical oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(17):JCO2002903, 1856-1864. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(17):JCO2002903, 1856-1864. AMER SOC CLINICAL ONCOLOGY
PURPOSEMutations in the HRAS (m HRAS) proto-oncogene occur in 4%-8% of patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Tipifarnib is a farnesyltransferase inhibitor that disrupts HRAS function. We evalua
Autor:
Pol Specenier
Publikováno v:
Expert review of pharmacoeconomics & outcomes research
Introduction: The immune checkpoint inhibitors, including nivolumab, and targeted agents have dramatically improved the outcome for patients with unresectable advanced melanoma. Areas covered: This is a narrative review of the published evidence on n
Autor:
Glen Meert, Cindy Kenis, Koen Milisen, Philip R. Debruyne, Inge De Groof, Christian Focan, Frank Cornélis, Vincent Verschaeve, Christian Bachmann, Dominique Bron, Heidi Van Den Bulck, Dirk Schrijvers, Christine Langenaeken, Pol Specenier, Guy Jerusalem, Jean-Philippe Praet, Jean-Pierre Lobelle, Johan Flamaing, Hans Wildiers, Lore Decoster
Publikováno v:
Journal of Geriatric Oncology
Introduction: Functional status (FS) and frailty are significant concerns for older adults, especially those with cancer. Data on FS (Activities of Daily Living [ADL]; Instrumental Activities of Daily Living [IADL]) and its evolution during cancer tr